Markos Marangos
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 20
-
- Antibiotic Resistance in Bacteria 29
- Co-authors
- Fotini FligouStelios F. AssimakopoulosMatthaios Papadimitriou‐OlivgerisEvangelos D. AnastassiouMyrto ChristofidouCharalambos GogosIris SpiliopoulouChristina Bartzavali
- Journals
- Infection (10 papers)Journal of Medical Microbiology (7 papers)Diagnostic Microbiology and Infectious Disease (6 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)Antibiotics (6 papers)
- Partner nations
- GreeceUnited StatesSwitzerland
In The Last Decade
Markos Marangos
174 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 136
- Applied Microbiology and Biotechnology 335
- Molecular Medicine 675
- Infectious Diseases 942
- Endocrinology 227
- Clinical Biochemistry 282
Countries citing papers authored by Markos Marangos
This map shows the geographic impact of Markos Marangos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markos Marangos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markos Marangos more than expected).
Fields of papers citing papers by Markos Marangos
This network shows the impact of papers produced by Markos Marangos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markos Marangos. The network helps show where Markos Marangos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markos Marangos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 28 | |
| 13 | 2022 | 4 | |
| 14 | 2021 | 23 | |
| 15 | 2021 | 5 | |
| 16 | 2019 | 8 | |
| 17 | 2017 | 12 | |
| 18 | 2015 | 2 | |
| 19 | 2011 | 9 | |
| 20 | 2008 | 14 |
About Markos Marangos
Markos Marangos is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Infectious Diseases, Clinical Biochemistry and Endocrinology, having authored 180 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (30 papers), Antibiotic Resistance in Bacteria (29 papers), COVID-19 Clinical Research Studies (25 papers), Bacterial Identification and Susceptibility Testing (23 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers), Antibiotic Use and Resistance (20 papers), Infective Endocarditis Diagnosis and Management (16 papers) and Long-Term Effects of COVID-19 (12 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (335 citations), Molecular Medicine (675 citations), Infectious Diseases (942 citations), Endocrinology (227 citations) and Clinical Biochemistry (282 citations). Markos Marangos has collaborated with scholars based in Greece, United States and Switzerland. Frequent co-authors include Fotini Fligou, Stelios F. Assimakopoulos, Matthaios Papadimitriou‐Olivgeris, Evangelos D. Anastassiou, Myrto Christofidou, Charalambos Gogos, Iris Spiliopoulou, Christina Bartzavali, Maria Lagadinou and Kriton S. Filos. Their work appears in journals such as Infection, Journal of Medical Microbiology, Diagnostic Microbiology and Infectious Disease, European Journal of Clinical Microbiology & Infectious Diseases and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.